Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

PFE

Pfizer Inc

Nov 03 • 04:00PM ET

24.66

+0.01 0.04 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN

| Held by: VTI VOO IVV SPY VTV XLV VYM VHT DVY FDL

Scroll to Statements

Index	S&P 500	P/E	13.12	EPS (ttm)	1.88	Insider Own	0.11%	Shs Outstand	5.68B	Perf Week	-0.44%
Market Cap	140.21B	Forward P/E	7.88	EPS next Y	3.13	Insider Trans	0.00%	Shs Float	5.68B	Perf Month	-9.90%
Enterprise Value	189.07B	PEG	-	EPS next Q	0.73	Inst Own	66.53%	Short Float	2.06%	Perf Quarter	-0.36%
Income	10.73B	P/S	2.20	EPS this Y	-2.23%	Inst Trans	-0.95%	Short Ratio	2.16	Perf Half Y	3.31%
Sales	63.83B	P/B	1.58	EPS next Y	2.87%	ROA	5.08%	Short Interest	116.82M	Perf YTD	-7.05%
Book/sh	15.60	P/C	10.58	EPS next 5Y	-0.45%	ROE	12.16%	52W High	28.54 -13.59%	Perf Year	-13.53%
Cash/sh	2.33	P/FCF	11.27	EPS past 3/5Y	-28.69% -13.27%	ROIC	7.34%	52W Low	20.92 17.91%	Perf 3Y	-46.09%
Dividend Est.	1.70 (6.89%)	EV/EBITDA	7.36	Sales past 3/5Y	-7.84% 9.10%	Gross Margin	67.34%	Volatility	1.86% 1.80%	Perf 5Y	-30.48%
Dividend TTM	1.71 (6.93%)	EV/Sales	2.96	EPS Y/Y TTM	510.84%	Oper. Margin	29.60%	ATR (14)	0.45	Perf 10Y	-23.83%
Dividend Ex-Date	Nov 07, 2025	Quick Ratio	0.85	Sales Y/Y TTM	14.72%	Profit Margin	16.81%	RSI (14)	48.46	Recom	2.46
Dividend Gr. 3/5Y	2.49% 2.97%	Current Ratio	1.16	EPS Q/Q	11938.10%	SMA20	-0.40%	Beta	0.42	Target Price	28.67
Payout	120.11%	Debt/Eq	0.70	Sales Q/Q	10.31%	SMA50	-0.45%	Rel Volume	2.63	Prev Close	24.65
Employees	81000	LT Debt/Eq	0.65	Earnings	Nov 04 BMO	SMA200	-0.00%	Avg Volume	54.03M	Price	24.66
IPO	Jan 17, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	37.53% 0.94%	Trades		Volume	140,871,296	Change	0.04%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47
Jan-17-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$54 → $50
Jan-04-23	Downgrade	BofA Securities	Buy → Neutral	$60

Show Previous Ratings

Today 08:17AM	Michael Burry buys puts on Nvidia, Palantir (Investing.com)
08:15AM	Earnings from Uber, Shopify, Spotify and Pfizer: Market Movers (Yahoo Finance Video)
08:17AM	Pfizer Raises Profit Outlook Even As Third-Quarter Sales Decline (Investor's Business Daily)
08:06AM	Pfizer files second lawsuit against Metsera, Novo Nordisk (TipRanks)
07:53AM	Earnings live: Spotify stock jumps on strong results, Palantir and Uber stocks fall (Yahoo Finance)
07:45AM	Loading…
07:45AM	These Stocks Are Moving the Most Today: Palantir, Sarepta, Tesla, Uber, Pfizer, Norwegian Cruise Line, Amazon, AMD, and More (Barrons.com)
07:37AM	Pfizer Stock Slips on Third-Quarter Earnings. What Covid-19 Has to Do With It. (Barrons.com)
07:35AM	Pfizer's $4.9 Billion Gamble: Inside Its Legal War to Reclaim the Obesity Market (GuruFocus.com)
07:20AM	Pfizer raises and narrows full-year earnings guidance (Investing.com)
07:04AM	Pfizer Profit Falls Amid Lower Covid-19 Drug Demand (The Wall Street Journal)
07:03AM	Pfizer: Q3 Earnings Snapshot (Associated Press Finance)
06:45AM	Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance (Business Wire)
05:46AM	Stocks to Watch Tuesday: Palantir, Sarepta, Tesla (The Wall Street Journal)
05:31AM	These Stocks Are Moving the Most Today: Palantir, Sarepta, Amazon, AMD, Pfizer, and More (Barrons.com)
05:05AM	Uber and AMD headline Tuesday's earnings (MarketWatch)
04:30AM	Loading…
04:30AM	Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? (Motley Fool)
04:29AM	Global Markets Fall After Fed Officials Express Diverging Views on Cuts (The Wall Street Journal)
04:13AM	McDonalds Earnings, Tariff Update, Musk Pay Vote: What to Watch This Week (The Wall Street Journal)
12:00AM	All megadeals lead to Washington (Financial Times)
Nov-03-25 07:00PM	AMD, Uber, Pfizer earnings on deck; ADP job data: What to Watch (Yahoo Finance Video)
06:17PM	Does the Market Have Bad Breadth? (Zacks)
04:32PM	Earnings live: Palantir stock rises modestly on strong results, Hims & Hers stock surges (Yahoo Finance)
04:11PM	Pfizer Reports Earnings Tuesday. Management Has Big Questions to Answer. (Barrons.com)
01:23PM	Did Novo Nordisk Just Say "Checkmate" to Pfizer? (Motley Fool)
12:47PM	Metsera Calls Pfizer's Claims 'Nonsense' In Latest Buyout Battle Salvo (Investor's Business Daily)
12:15PM	Pfizer files second lawsuit to block Novo Nordisks $9bn Metsera bid (Financial Times)
12:03PM	Pfizer Aligns With Trump on Drug Pricing In Its Bid for Biotech Metsera (Barrons.com)
11:26AM	Stock Market Today: Stocks Rebound Midday After Amazon, Microsoft Announce New AI Deals (TheStreet)
11:13AM	Viking Therapeutics Could Be Pharmas Next Big Buyout Target (24/7 Wall St.)
11:06AM	Jim Cramer on Pfizer: "We'll Find Out if Pfizer's Going to Be More of a Stock and Less of a Bond Equivalent" (Insider Monkey)
09:34AM	Loading…
09:34AM	Kimberly-Clark to buy Tylenol maker Kenvue, Iren & Microsoft deal (Yahoo Finance Video)
09:19AM	Pfizer Files Antitrust Suit to Block Novo Nordisk Acquisition of Metsera (The Wall Street Journal)
08:06AM	Earnings live: Berkshire Hathaway profits rise, Beyond Meat postpones earnings, with Palantir results on deck (Yahoo Finance)
08:06AM	Earnings live: Berkshire Hathaway profits rise as Buffett prepares to step down; Palantir results on deck (Yahoo Finance)
07:57AM	Pfizer Files Federal Antitrust Claims in Second Lawsuit Against Metsera, its Controlling Stockholders and Novo Nordisk (Business Wire)
07:44AM	Pfizer hits Novo Nordisk and Metsera with lawsuit amid bidding war (Pharmaceutical Technology)
07:37AM	2 Healthcare Stocks for Individual Investors With a 20-Year Time Horizon (Motley Fool)
06:43AM	Stocks to Watch Monday: Kenvue, Kimberly-Clark, Berkshire Hathaway (The Wall Street Journal)
05:22AM	ESMO 2025: Celcuity gets first positive results for Pi3K inhibitor in PiK3CA wild-type HR+/HER2 breast cancer (Clinical Trials Arena)
04:46AM	Meet the 7% Yield Dividend Stock That Could Soar in 2026 (Motley Fool)
04:00AM	1 Incredible Reason to Buy Pfizer Stock (PFE) in November (Motley Fool)
02:42AM	McDonalds Earnings, Tariff Update, Musk Pay Vote: What to Watch This Week (The Wall Street Journal)
Nov-02-25 10:02PM	Pfizer (PFE) Q3 Earnings: What To Expect (StockStory)
02:00PM	Palantir, AMD, Pfizer, Robinhood, McDonald's, and Many More Stocks to Watch This Week (Barrons.com)
07:40AM	Fed fallout, missing jobs numbers, and a busy earnings calendar: What to watch this week (Yahoo Finance)
05:30AM	Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk (The Wall Street Journal)
04:20AM	Is It Time to Dump Your Shares of Pfizer? (Motley Fool)
Nov-01-25 11:46AM	Pfizer sues Metsera, Novo in effort to enforce buyout deal (BioPharma Dive)
Oct-31-25 06:44PM	Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal (The Wall Street Journal)
05:30PM	Pfizer Sues Novo Nordisk And Metsera To Block The Proposed $6.5 Billion Deal (Investor's Business Daily)
05:28PM	Pfizer sues to stop rival bid for drugmaker Metsera by Denmark's Novo Nordisk (Associated Press Finance)
05:12PM	Earnings live: Amazon stock soars, Apple pares gains with earnings from AI players to come (Yahoo Finance)
04:37PM	Pfizer Files Lawsuit Against Metsera and its Directors and Novo Nordisk for Breach of Merger Agreement (Business Wire)
03:50PM	Pfizer Receives Early Clearance from U.S. Federal Trade Commission for Metsera Acquisition (Business Wire)
12:36PM	Health Care Roundup: Market Talk (The Wall Street Journal)
11:07AM	Pfizer Q3 Earnings Loom: Buy, Sell or Hold PFE Stock Ahead of Results? (Zacks)
10:28AM	Novo Nordisk cuts 9,000 jobs as it looks to new weight-loss drugs (Reuters Videos)
08:25AM	Pfizer Faces Off With Novo Nordisk Over Metsera Bid (GuruFocus.com)
08:20AM	AbbVie Beats Third-Quarter Estimates. There's More to the Drugmaker's Earnings. (Barrons.com)
06:30AM	Eli Lillys Sterling Results Highlight Rival Novo Nordisks Fading Fortunes (The Daily Upside)
Oct-30-25 10:30PM	Jim Cramer on Pfizer: "The Drug Stocks Are Just in a World of Hurt, and This One Continues to Be There" (Insider Monkey)
06:00PM	The Day Pharmas Weight-Loss Gold Rush Intensified (The Wall Street Journal)
05:50PM	Pfizer Fires Back as Novo Nordisk Hijacks Its $8.5 Billion Metsera Deal (GuruFocus.com)
04:35PM	Stocks to Watch Thursday Recap: Eli Lilly, Metsera, Navan, Chipotle (The Wall Street Journal)
04:15PM	Alnylam Stock Has Almost Doubled In 2025. But It Took A Hit On Earnings. (Investor's Business Daily)
04:13PM	Novo Nordisk Kicks Off Bloody Battle With Pfizer, Bidding $6.5 Billion On Metsera (Investor's Business Daily)
03:51PM	Meta Sells $30 Billion of Bonds as AI Frenzy Fuels Record Orders (Bloomberg)
03:03PM	Novo Nordisk takes on Pfizer in bid for obesity biotech Metsera (Reuters Videos)
02:16PM	Pfizer said to mull suing Novo Nordisk over Metsera bid (Investing.com)
02:11PM	Novo Nordisk Tries to Snatch a Weight-Loss Biotech From Pfizer. There Are Political Risks. (Barrons.com)
02:05PM	CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Buy? (Zacks)
01:44PM	Analyst Report: Haleon plc (Morningstar Research)
01:31PM	Bidding war rises over weight loss drug that could prevent Ozempic face (The Telegraph)
01:11PM	Chipotle drags fast casual stocks lower, Meta reports raising $125B (Yahoo Finance Video)
12:52PM	Novo Nordisk Seeks to Outmuscle Pfizer With $9 Billion Bid for Metsera (The Wall Street Journal)
11:23AM	Novo Nordisk locks horns with Pfizer in late bid for Metsera (Pharmaceutical Technology)
10:41AM	Stocks to Watch Thursday: Eli Lilly, Metsera, Navan, Chipotle (The Wall Street Journal)
10:39AM	Obesity, diabetes treatments fuel Eli Lilly growth and spark bidding war (Associated Press Finance)
10:32AM	BMY Beats on Q3 Earnings and Sales, Raises 2025 Sales View (Zacks)
10:04AM	Novo, Pfizer Square Off Over Metsera in Obesity-Drug Tussle (Bloomberg)
09:56AM	Singapore Approves Latest Pfizer/BioNTech COVID-19 Vaccine for All Ages (Insider Monkey)
09:49AM	Alnylam Stock Has Already Doubled In 2025. But It Took A Hit On Earnings. (Investor's Business Daily)
09:25AM	Novo Nordisk's bid for Metsera, Eli Lilly boosts revenue outlook (Yahoo Finance Video)
09:22AM	Eli Lilly Stock Rises on Earnings as Investors Await Trump Drug Pricing Deal (Barrons.com)
09:15AM	What Analyst Projections for Key Metrics Reveal About Pfizer (PFE) Q3 Earnings (Zacks)
09:13AM	Novo Nodrisk stock dips on aggressive odder to buy Metsera, reckless says Pfizer (Investing.com)
08:20AM	Novo Nordisk launches bidding war with Pfizer for obesity drugmaker Metsera (AFP)
07:57AM	Mounjaro Powers Eli Lilly to Bumper Quarter of Earnings (The Wall Street Journal)
07:45AM	Merck (MRK) Q3 Earnings and Revenues Beat Estimates (Zacks)
07:11AM	Metsera Stock Soars. Novo Nordisk Looks to Outbid Pfizer for the Obesity-Drug Maker. (Barrons.com)
06:57AM	Pfizer Addresses Proposal for Metsera (Business Wire)
06:51AM	Merck Stock Falls After Earnings. Keytruda Sales Top $8 Billion for First Time. (Barrons.com)
06:32AM	Pfizer and Roche place $10bn bets on obesity and liver disease therapies as Trump tightens grip on drug pricing and manufacturing (Pharmaceutical Technology)
06:23AM	Novo Nordisk Moves to Outbid Pfizer With Up to $9 Billion Offer for Obesity Drug Developer Metsera (The Wall Street Journal)
04:15AM	Prediction: Putting $1,000 Into These Dividend Stocks Could Pay Off for Years (Motley Fool)
Oct-29-25 07:00PM	2 High-Yield Stocks With Fresh Catalysts (Motley Fool)
04:45PM	Eli Lilly Reports Earnings Thursday as Investors Await Trump Drug Pricing Deal (Barrons.com)
04:30PM	Merck Reports Earnings Under Shadow of Keytruda Patent Cliff. What to Expect. (Barrons.com)
11:18AM	Berenberg Bank Maintains a Hold on Pfizer Inc (PFE), Ahead of Q3 Earnings (Insider Monkey)
09:27AM	Pfizer Stock: Is Wall Street Bullish or Bearish? (Barchart)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dolsten Mikael	Former Officer	May 23 '25	Proposed Sale	23.09	59,781	1,380,632		May 23 10:54 AM
Dolsten Mikael	Former Officer	May 05 '25	Proposed Sale	23.87	55,000	1,312,736		May 05 04:45 PM
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27 '25	Option Exercise	31.31	22,416	701,845	31,063	Mar 03 05:39 PM
SUSMAN SALLY	Executive Vice President	Feb 27 '25	Option Exercise	31.31	85,182	2,667,048	250,866	Mar 03 05:38 PM
SAHNI PAYAL	Executive Vice President	Feb 27 '25	Option Exercise	31.31	19,054	596,581	44,242	Mar 03 05:38 PM
McDermott Michael	Executive Vice President	Feb 27 '25	Option Exercise	31.31	48,419	1,515,999	122,413	Mar 03 05:37 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27 '25	Option Exercise	31.31	156,914	4,912,977	309,790	Mar 03 05:37 PM
Fonseca Lidia	Executive Vice President	Feb 27 '25	Option Exercise	31.31	72,629	2,274,014	111,534	Mar 03 05:36 PM
BOURLA ALBERT	Chairman & CEO	Feb 27 '25	Option Exercise	31.31	582,823	18,248,188	931,744	Mar 03 05:36 PM
McDermott Michael	Executive Vice President	Feb 22 '25	Option Exercise	30.17	11,125	335,641	87,636	Feb 25 07:38 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22 '25	Option Exercise	30.17	8,741	263,716	17,602	Feb 25 07:38 PM
BOURLA ALBERT	Chairman & CEO	Feb 22 '25	Option Exercise	30.17	238,399	7,192,498	570,436	Feb 25 07:06 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 22 '25	Option Exercise	30.17	85,824	2,589,310	232,775	Feb 25 07:05 PM
SAHNI PAYAL	Executive Vice President	Feb 22 '25	Option Exercise	30.17	12,714	383,581	37,099	Feb 25 07:04 PM
SUSMAN SALLY	Executive Vice President	Feb 22 '25	Option Exercise	30.17	63,573	1,917,997	225,184	Feb 25 07:02 PM
BOSHOFF CHRISTOFFEL	President, R&D	Feb 22 '25	Option Exercise	30.17	8,741	263,716	159,085	Feb 25 06:58 PM
BLAYLOCK RONALD E	Director	Feb 13 '25	Buy	25.65	19,457	499,072	27,707	Feb 14 05:16 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc

Upgrade your FINVIZ experience